HR 8641 · 117th Congress · Health

Orphan Drug COVID–19 Mitigation Act of 2022

Introduced 2022-08-02· Sponsored by Rep. Gottheimer, Josh [D-NJ-5]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Energy and Commerce.(2022-08-02)

Plain Language Summary

[AI summary unavailable — showing source text] Orphan Drug COVID-19 Mitigation Act of 2022 This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (3)

2 Democrats1 Republican